GlobeNewswire Clinical StudiesOriginal article
HCW Biologics’ TGF-β Trap and IL-15 Fusion is a Novel Moiety to Enhance Immunotherapeutic Activity against Diseased Cells
Data ReadoutpositiveTGF-β Trap and IL-15 FusionPositive
AI Analysis
Summary
HCW Biologics reported human study data showing its TGF-β trap and IL-15 fusion candidate promotes expansion of progenitor CD8+ T cells and NK cells, demonstrating potential immunotherapeutic activity.
Clinical Trial Data
Outcome Details
Human studies show TGF-β trap and IL-15 fusion promotes expansion of progenitor CD8+ T cells and NK cells
Importance:4/10
Sentiment:
0.60
immunotherapyTGF-betaIL-15CD8+ T cellsNK cellsclinical data
Read the original article
Published by GlobeNewswire Clinical Studies on August 25, 2026 1:00 PM